Eco Animal Health Group Plc

LSE:EAH UK Drug Manufacturers - Specialty & Generic
Market Cap
$787.66K
GBX6.47 Billion GBX
Market Cap Rank
#45228 Global
#859 in UK
Share Price
GBX96.50
Change (1 day)
-1.03%
52-Week Range
GBX51.50 - GBX114.00
All Time High
GBX636.45
About

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatm… Read more

Eco Animal Health Group Plc (EAH) - Net Assets

Latest net assets as of September 2025: GBX92.39 Million GBX

Based on the latest financial reports, Eco Animal Health Group Plc (EAH) has net assets worth GBX92.39 Million GBX as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX113.96 Million) and total liabilities (GBX21.57 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX92.39 Million
% of Total Assets 81.07%
Annual Growth Rate 8.47%
5-Year Change -0.58%
10-Year Change 11.02%
Growth Volatility 19.76

Eco Animal Health Group Plc - Net Assets Trend (1990–2025)

This chart illustrates how Eco Animal Health Group Plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Eco Animal Health Group Plc (1990–2025)

The table below shows the annual net assets of Eco Animal Health Group Plc from 1990 to 2025.

Year Net Assets Change
2025-03-31 GBX94.77 Million +1.48%
2024-03-31 GBX93.38 Million -2.27%
2023-03-31 GBX95.55 Million +1.28%
2022-03-31 GBX94.35 Million -1.01%
2021-03-31 GBX95.31 Million +18.48%
2020-03-31 GBX80.45 Million -10.19%
2019-03-31 GBX89.58 Million -14.59%
2018-03-31 GBX104.88 Million +6.83%
2017-03-31 GBX98.17 Million +15.01%
2016-03-31 GBX85.36 Million +11.90%
2015-03-31 GBX76.28 Million +4.77%
2014-03-31 GBX72.81 Million +20.76%
2013-03-31 GBX60.29 Million +3.51%
2012-03-31 GBX58.25 Million +0.83%
2011-03-31 GBX57.77 Million +3.71%
2010-03-31 GBX55.70 Million +12.30%
2009-03-31 GBX49.60 Million -0.29%
2008-03-31 GBX49.74 Million +37.39%
2007-03-31 GBX36.21 Million +3.88%
2006-03-31 GBX34.85 Million -3.75%
2005-03-31 GBX36.21 Million +63.73%
2004-03-31 GBX22.12 Million +18.98%
2003-03-31 GBX18.59 Million +13.16%
2002-03-31 GBX16.43 Million +19.71%
2001-03-31 GBX13.72 Million +13.69%
2000-03-31 GBX12.07 Million +15.22%
1999-03-31 GBX10.48 Million +7.26%
1998-03-31 GBX9.77 Million +27.19%
1997-03-31 GBX7.68 Million -13.53%
1996-03-31 GBX8.88 Million +10.63%
1995-03-31 GBX8.03 Million -16.07%
1994-03-31 GBX9.56 Million +83.45%
1993-03-31 GBX5.21 Million +8.83%
1992-06-30 GBX4.79 Million -13.19%
1991-06-30 GBX5.52 Million -1.67%
1990-06-30 GBX5.61 Million --

Equity Component Analysis

This analysis shows how different components contribute to Eco Animal Health Group Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 689.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Retained Earnings GBX17.87 Million 20.90%
Common Stock GBX3.39 Million 3.96%
Other Comprehensive Income GBX853.00K 1.00%
Other Components GBX63.39 Million 74.14%
Total Equity GBX85.50 Million 100.00%

Eco Animal Health Group Plc Competitors by Market Cap

The table below lists competitors of Eco Animal Health Group Plc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Eco Animal Health Group Plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 83,690,000 to 85,499,000, a change of 1,809,000 (2.2%).
  • Net income of 1,686,000 contributed positively to equity growth.
  • Dividend payments of 1,065,000 reduced retained earnings.
  • New share issuances of 1,000 increased equity.
  • Other comprehensive income decreased equity by 312,000.
  • Other factors increased equity by 1,499,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income GBX1.69 Million +1.97%
Dividends Paid GBX1.06 Million -1.25%
Share Issuances GBX1.00K +0.0%
Other Comprehensive Income GBX-312.00K -0.36%
Other Changes GBX1.50 Million +1.75%
Total Change GBX- 2.16%

Book Value vs Market Value Analysis

This analysis compares Eco Animal Health Group Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 78.38x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 350.37x to 78.38x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1990-06-30 GBX0.28 GBX96.50 x
1991-06-30 GBX0.27 GBX96.50 x
1992-06-30 GBX0.28 GBX96.50 x
1993-03-31 GBX0.30 GBX96.50 x
1994-03-31 GBX0.56 GBX96.50 x
1995-03-31 GBX0.47 GBX96.50 x
1996-03-31 GBX0.49 GBX96.50 x
1997-03-31 GBX0.42 GBX96.50 x
1998-03-31 GBX0.46 GBX96.50 x
1999-03-31 GBX0.51 GBX96.50 x
2000-03-31 GBX0.58 GBX96.50 x
2001-03-31 GBX0.63 GBX96.50 x
2002-03-31 GBX0.73 GBX96.50 x
2003-03-31 GBX0.69 GBX96.50 x
2004-03-31 GBX0.78 GBX96.50 x
2005-03-31 GBX1.27 GBX96.50 x
2006-03-31 GBX1.11 GBX96.50 x
2007-03-31 GBX1.09 GBX96.50 x
2008-03-31 GBX1.48 GBX96.50 x
2009-03-31 GBX1.06 GBX96.50 x
2010-03-31 GBX1.13 GBX96.50 x
2011-03-31 GBX1.04 GBX96.50 x
2012-03-31 GBX1.07 GBX96.50 x
2013-03-31 GBX1.08 GBX96.50 x
2014-03-31 GBX1.25 GBX96.50 x
2015-03-31 GBX1.22 GBX96.50 x
2016-03-31 GBX1.30 GBX96.50 x
2017-03-31 GBX1.44 GBX96.50 x
2018-03-31 GBX1.50 GBX96.50 x
2019-03-31 GBX1.25 GBX96.50 x
2020-03-31 GBX1.06 GBX96.50 x
2021-03-31 GBX1.21 GBX96.50 x
2022-03-31 GBX1.21 GBX96.50 x
2023-03-31 GBX1.21 GBX96.50 x
2024-03-31 GBX1.21 GBX96.50 x
2025-03-31 GBX1.23 GBX96.50 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Eco Animal Health Group Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 1.97%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 2.12%
  • • Asset Turnover: 0.66x
  • • Equity Multiplier: 1.41x
  • Recent ROE (1.97%) is below the historical average (9.17%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1990 8.14% 13.37% 0.52x 1.17x GBX-104.20K
1991 11.11% 11.78% 0.79x 1.20x GBX61.20K
1992 12.86% 10.22% 1.04x 1.21x GBX137.60K
1993 12.47% 12.71% 0.79x 1.25x GBX129.20K
1994 47.75% 57.17% 0.76x 1.10x GBX3.62 Million
1995 7.20% 9.00% 0.53x 1.50x GBX-226.80K
1996 13.86% 9.15% 1.12x 1.35x GBX345.40K
1997 19.08% 9.85% 0.95x 2.04x GBX704.20K
1998 19.95% 11.09% 1.07x 1.68x GBX979.40K
1999 19.08% 8.69% 1.12x 1.96x GBX1.01 Million
2000 16.98% 8.00% 1.12x 1.90x GBX873.60K
2001 14.88% 6.36% 1.20x 1.95x GBX665.00K
2002 -1.21% -0.58% 1.14x 1.84x GBX-1.81 Million
2003 16.44% 8.04% 1.18x 1.73x GBX1.14 Million
2004 20.55% 12.89% 0.98x 1.63x GBX2.21 Million
2005 7.34% 15.61% 0.39x 1.21x GBX-962.90K
2006 -0.12% -0.21% 0.44x 1.33x GBX-3.53 Million
2007 7.79% 19.18% 0.31x 1.31x GBX-800.50K
2008 -1.60% -4.76% 0.30x 1.12x GBX-5.69 Million
2009 0.81% 2.07% 0.35x 1.12x GBX-4.46 Million
2010 2.28% 5.69% 0.34x 1.18x GBX-4.19 Million
2011 2.84% 5.88% 0.42x 1.15x GBX-4.01 Million
2012 3.94% 7.83% 0.40x 1.24x GBX-3.42 Million
2013 4.52% 9.03% 0.41x 1.21x GBX-3.17 Million
2014 3.44% 7.63% 0.40x 1.13x GBX-4.63 Million
2015 5.59% 10.50% 0.44x 1.22x GBX-3.23 Million
2016 7.35% 12.81% 0.49x 1.18x GBX-2.18 Million
2017 11.26% 17.20% 0.54x 1.21x GBX1.18 Million
2018 9.34% 13.86% 0.57x 1.18x GBX-654.00K
2019 8.59% 10.78% 0.63x 1.26x GBX-1.19 Million
2020 5.22% 5.40% 0.72x 1.34x GBX-3.57 Million
2021 8.96% 6.95% 0.90x 1.43x GBX-853.10K
2022 -0.84% -0.83% 0.72x 1.38x GBX-8.89 Million
2023 1.21% 1.18% 0.70x 1.46x GBX-7.32 Million
2024 1.25% 1.17% 0.73x 1.47x GBX-7.32 Million
2025 1.97% 2.12% 0.66x 1.41x GBX-6.86 Million

Industry Comparison

This section compares Eco Animal Health Group Plc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $4,140,414,263
  • Average return on equity (ROE) among peers: 2.35%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Eco Animal Health Group Plc (EAH) GBX92.39 Million 8.14% 0.23x $8.46K
Animalcare Group Plc (ANCR) $78.80 Million -0.10% 0.40x $23.67K
Alliance Pharma plc (APH) $16.63 Million 24.70% 2.42x $42.55K
Beximco Pharmaceuticals Limited (BXP) $32.80 Billion 10.72% 0.53x $31.61K
Celadon Pharmaceuticals PLC (CEL) $6.41 Million -74.61% 0.03x $1.12K
Hellenic Dynamics PLC (HELD) $-102.20K 0.00% 0.00x $1.10
Indivior PLC (INDV) $209.00 Million 64.11% 6.90x $187.94K
N4 Pharma PLC (N4P) $7.54 Million 9.68% 0.74x $632.90
Provexis plc (PXS) $7.58 Million -15.68% 0.05x $3.45K